BridgeMD
Compares treatment options for Back Pain
Official title Erector Spinae Plane Block Versus Trigger Point Injection for Chronic Thoracic Myofascial Pain
ClinicalTrials.gov ID: NCT07632820
What this study is testing
What is Erector Spinae Plane (ESP) Block with 0.5% Plain Bupivacaine?
Erector Spinae Plane (ESP) Block with 0.5% Plain Bupivacaine is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for back pain.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Chronic thoracic (mid-back) pain can be difficult to treat, and there is limited evidence to guide the use of injection therapies for pain arising from muscles and surrounding soft tissues. Two commonly used treatments are trigger point injections (TPI) and erector spinae plane (ESP) blocks, but no studies have directly compared their effectiveness for chronic thoracic myofascial pain.
- Phase 4: studies an already-approved treatment
- Time commitment: about 12 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Adults aged 18-80 years
- Chronic thoracic myofascial pain lasting at least three months
- Pain intensity of ≥4 on 11-point NRS
- At least two of three following conditions: Focal thoracic paraspinal pain, palpable taut band, referred pain pattern with palpation
You likely can't join if
- Thoracic radiculopathy
- Cervical myelopathy with neurological deficit
- Prior cervicothoracic spine surgery
- Pregnancy or lactation
- Contraindication to local anesthetic
- Active malignancy
See the full eligibility criteria
- Adults aged 18-80 years
- Chronic thoracic myofascial pain lasting at least three months
- Pain intensity of ≥4 on 11-point NRS
- At least two of three following conditions: Focal thoracic paraspinal pain, palpable taut band, referred pain pattern with palpation
- Thoracic radiculopathy
- Cervical myelopathy with neurological deficit
- Prior cervicothoracic spine surgery
- Pregnancy or lactation
- Contraindication to local anesthetic
- Active malignancy
- Fibromyalgia
- BMI \>40 kg/m2
- Workers' compensation or active litigation related to thoracic pain
- Acute herpes zoster or history of postherpetic neuralgia involving thoracic dermatomes
- Current opioid use \>50 morphine milligram equivalents daily
- Severe psychiatric or cognitive disorders, specifically history of schizophrenia, chronic psychotic disorders, dementia
- History of substance use disorder
- Inability to provide informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Jacksonville, Florida, United States
- Baltimore, Maryland, United States
- Rochester, Minnesota, United States
- Columbus, Ohio, United States
- Houston, Texas, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jacksonville, Florida, United States; Baltimore, Maryland, United States; Rochester, Minnesota, United States; Columbus, Ohio, United States; Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.